PIK3CA and neoplasm: In contrast to TP53, the allelic fraction of PIK3CA mutants was proportional to the tumor cellularity (Figure 4B), with the exception of two tumors (Figure 4B, red box) of high cellularity (>80%) and lower PIK3CA mutant allelic fraction (<30%), indicating that the mutations may have been present in only a subset of the tumor cells.